UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): July 22, 2005

 

SILICON LABORATORIES INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

000-29823

 

74-2793174

(State or Other Jurisdiction

 

(Commission File Number)

 

(IRS Employer

of Incorporation)

 

 

 

Identification No.)

 

4635 Boston Lane, Austin, TX 78735

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (512) 416-8500

 

Not Applicable

(Former Name or Former Address, if Changed since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

On July 22, 2005, Silicon Laboratories Inc. issued a press release describing its results of operations for its fiscal quarter ended July 2, 2005.  A copy of the press release is attached as Exhibit 99 to this report.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

 

(c)  Exhibits.

 

99  Press Release of Silicon Laboratories Inc. dated July 22, 2005.

 

Use of Non-GAAP Financial Information

 

From time to time, Silicon Laboratories provides certain non-GAAP financial measures as additional information relating to its operating results.  The non-GAAP financial measurements provided in the press release furnished herewith do not replace the presentation of Silicon Laboratories’ GAAP financial results. These additional measurements merely provide supplemental information to assist investors in analyzing Silicon Laboratories’ financial position and results of operations; however, these measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Silicon Laboratories has chosen to provide this information to investors because it believes that such supplemental information enables them to perform meaningful comparisons of past, present and future operating results, and as a means to highlight the results of core ongoing operations.

 

Pursuant to the requirements of Regulation G, we have provided in the press release furnished with this report a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

 

The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.  The information contained therein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Silicon Laboratories, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

SILICON LABORATORIES INC.
                (Registrant)

 

 

 

 

 

 

 

July 22, 2005

 

/s/ Russell J. Brennan

 

Date

 

Russell J. Brennan
VICE PRESIDENT AND
CHIEF FINANCIAL OFFICER
(PRINCIPAL ACCOUNTING OFFICER)

 

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99

 

Press release dated July 22, 2005 of the Registrant

 

4


 

Exhibit 99

 

 

NEWS RELEASE

 

SILICON LABORATORIES REPORTS STRONG SECOND QUARTER PERFORMANCE

 

AUSTIN, Texas – July 22, 2005 – Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal ICs, today reported revenues of $107 million and fully diluted GAAP earnings of $0.28 per share.

 

Financial Results

 

“I am very pleased with the strong financial performance during the quarter.  We continue to run a very healthy, profitable business that is well positioned to strongly invest in R&D to drive long-term revenue growth,” said Russ Brennan, chief financial officer of Silicon Laboratories.

 

GAAP operating income for the second quarter was $18 million dollars or 17 percent of revenue.  Excluding a $0.6 million non-cash charge for amortization of deferred stock compensation and a one time CEO severance charge of $1.9 million dollars, adjusted operating income for the second quarter was $20.4 million dollars, representing 19 percent of revenue which exceeded expectations.   The company ended the quarter with cash and short-term investments up approximately $27 million to $330 million.  The reconciling charges are set forth in the reconciliation of GAAP to non-GAAP financial measures table included below.

 

Business Summary

 

During the quarter, the broad-based mixed-signal business represented slightly more than half of total revenue and continued to diversify as adoption in the ProSLIC, MCU and Networking product lines increased.  The company’s recently announced digital power products experienced a high level of design activity among the leading providers of switched mode power supplies.

 



 

The company also continued to see a high level of design activity and development tool demand for the MCU products, which posted revenue growth again in Q2.  Both product lines are contributing to the company’s expansion into highly fragmented, highly profitable mixed-signal markets.

 

Mobile handset revenues increased by four percent during the quarter as demand recovered among customers in southeast Asia.  Aero® II, the industry’s most integrated RF transceiver for handsets, represented almost 40 percent of new design wins.  Design activity on the company’s recently announced FM tuner in both handset and MP3 devices is expected to result in production shipments in the third quarter of this year, three months earlier than anticipated.

 

“I am very excited by the revenue potential of our recently announced new products as well as those in our pipeline,” said Nav Sooch, chairman and interim-chief executive officer. “After a close review of all of our R&D projects, I am confident that we are investing in the right activities to accelerate our revenue growth, increase our customer, market and product diversity and further improve our profitability.”

 

The company anticipates revenue of $100 to $103 million in the third quarter of 2005.

 

Conference Call Today

 

A conference call discussing the second quarter results will follow the release at 7 a.m. Eastern Time.  An audio webcast will be available simultaneously on Silicon Laboratories’ website under Investor Relations (www.silabs.com).  A replay will be available after the call at the same website listed above or by calling 800-513-1173 (U.S.) or +1 402-344-6829 (international). These replays will be available through August 5, 2005.

 

About Silicon Laboratories Inc.

 

Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications.  Silicon Laboratories’ diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with decades of cumulative expertise in cutting-edge mixed-signal design.

 



 

The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories please visit www.silabs.com.

 

Cautionary Language

 

This press release contains forward-looking statements based on Silicon Laboratories’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly, especially for mobile handset products; dependence on a limited number of products and customers; risks associated with shifting market demand from GSM/GPRS to EDGE and WCDMA; difficulties developing new products that achieve market acceptance; risks that Silicon Laboratories may not be able to manage strains associated with its growth; dependence on key personnel; difficulties managing our manufacturers and subcontractors; difficulties managing international activities; credit risks associated with our accounts receivable; geographic concentration of manufacturers, assemblers, test service providers and customers in the Pacific Rim that subjects Silicon Laboratories’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; product development risks; inventory-related risks; intellectual property litigation risks; risks associated with acquisitions; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories’ filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Note to editors: Silicon Laboratories, ProSLIC, Aero and the Silicon Laboratories logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Silicon Laboratories Inc., Shannon Pleasant, 512/464-9254 investor.relations@silabs.com

 



 

Silicon Laboratories Inc.

Unaudited Condensed Consolidated Statements of Income

(in thousands, except per share data)

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

July 2,
2005

 

July 3,
2004

 

July 2,
2005

 

July 3,
2004

 

Revenues

 

$

107,156

 

$

126,130

 

$

211,920

 

$

239,753

 

Cost of revenues

 

48,566

 

57,544

 

97,116

 

109,410

 

Gross profit

 

58,590

 

68,586

 

114,804

 

130,343

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

20,895

 

17,867

 

39,862

 

36,009

 

Selling, general and administrative

 

19,137

 

16,650

 

35,858

 

31,854

 

Amortization of deferred stock  compensation

 

649

 

1,163

 

1,402

 

2,400

 

Operating expenses

 

40,681

 

35,680

 

77,122

 

70,263

 

Operating income

 

17,909

 

32,906

 

37,682

 

60,080

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

1,992

 

591

 

3,404

 

1,070

 

Interest expense

 

(45

)

(115

)

(101

)

(165

)

Other income (expense), net

 

(178

)

193

 

(193

)

2,008

 

Income before income taxes

 

19,678

 

33,575

 

40,792

 

62,993

 

Provision for income taxes

 

4,064

 

10,769

 

7,805

 

20,272

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

15,614

 

$

22,806

 

$

32,987

 

$

42,721

 

Net income per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.29

 

$

0.44

 

$

0.62

 

$

0.84

 

Diluted

 

$

0.28

 

$

0.41

 

$

0.60

 

$

0.77

 

Weighted-average common shares  outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

53,149

 

51,328

 

52,807

 

51,161

 

Diluted

 

55,027

 

55,294

 

55,196

 

55,293

 

 



 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(in thousands, except per share data)

 

 

 

Three Months Ended

 

 

 

July 2,
2005

 

July 3,
2004

 

GAAP operating income

 

$

17,909

 

$

32,906

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

CEO separation agreement charge

 

1,858

 

 

Amortization of deferred stock compensation

 

649

 

1,163

 

Adjusted operating income

 

$

20,416

 

$

34,069

 

 

 

 

 

 

 

Adjusted operating income %

 

19

%

27

%

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(in thousands, except per share data)

 

 

 

July 2,
2005

 

January 1,
2005

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

224,213

 

$

48,636

 

Short-term investments

 

106,158

 

228,470

 

Accounts receivable, net of allowance for  doubtful accounts of $1,464 at July 2, 2005 and $1,088 at January 1, 2005

 

59,814

 

46,272

 

Inventories

 

28,407

 

38,405

 

Deferred income taxes

 

10,131

 

9,878

 

Prepaid expenses and other

 

4,432

 

5,244

 

Total current assets

 

433,155

 

376,905

 

Property, equipment and software, net

 

29,539

 

34,559

 

Goodwill

 

65,989

 

46,766

 

Other intangible assets, net

 

14,174

 

15,384

 

Other assets, net

 

12,693

 

10,788

 

Total assets

 

$

555,550

 

$

484,402

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

32,937

 

$

37,001

 

Accrued expenses

 

13,302

 

11,913

 

Deferred income on shipments to distributors

 

31,351

 

25,227

 

Income taxes payable

 

13,909

 

8,207

 

Total current liabilities

 

91,499

 

82,348

 

Long-term obligations and other liabilities

 

1,849

 

2,570

 

Total liabilities

 

93,348

 

84,918

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock—$.0001 par value; 10,000  shares authorized; no shares issued and  outstanding

 

 

 

Common stock—$.0001 par value; 250,000  shares authorized; 53,738 and 52,508  shares issued and outstanding at  July 2, 2005 and January 1, 2005, respectively

 

5

 

5

 

Additional paid-in capital

 

314,586

 

287,908

 

Deferred stock compensation

 

(1,734

)

(4,787

)

Retained earnings

 

149,345

 

116,358

 

Total stockholders’ equity

 

462,202

 

399,484

 

Total liabilities and stockholders’ equity

 

$

555,550

 

$

484,402

 

 

 

##